(53) also found that tumor-associated macrophages(TAMs) stimulated STAT3 to promote production of LCSC through the secretion of IL-6; the activation of IL-6/STAT3 signals promotes liver cancer cells to produce LCSC, facilitating the resistance of liver cancer cells to sorafenib (54). Here, STAT3 is linked to liver cancer.